Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you live in Northern Ireland and are looking into weight loss injections, the two medicines licensed in the UK for this purpose are tirzepatide (Mounjaro) and semaglutide (Wegovy). Both are prescription-only, which means a qualified prescriber must assess your suitability before any treatment can be dispensed. You don't need to visit a clinic in person — a regulated online pharmacy can carry out that assessment remotely, with a GPhC-registered Independent Prescriber reviewing your consultation the same day. This page explains how both medicines work, who qualifies, how NHS access works in Northern Ireland, and what the private route looks like if you'd rather not wait.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you've been looking at weight loss injections for a while. You've seen them mentioned in the news, perhaps a friend has started them, and now you want to know whether they're accessible where you live. The good news is that geography is largely irrelevant for private treatment, a GPhC-registered online pharmacy can assess and dispatch to a Northern Ireland address just as easily as anywhere else in the UK.
The two licensed options are quite different in how they work. Tirzepatide activates two gut-hormone receptors (GIP and GLP-1), which helps reduce appetite and slow digestion. Semaglutide targets the GLP-1 receptor alone. Both are once-weekly subcutaneous injections. In clinical trials, tirzepatide produced average weight reductions of around 20–21% over 72 weeks at the highest dose, as reported in the SURMOUNT-1 trial published in the New England Journal of Medicine. Semaglutide at 2.4mg produced around 15% average loss over 68 weeks in the STEP 1 trial. These are population averages from controlled studies, individual results vary, and a prescriber will help you understand what's realistic for your situation.
If needles are a concern, it's worth knowing that a licensed oral option now exists too. The MHRA approved Wegovy tablets in June 2026, making it the first oral GLP-1 medicine for weight management in the UK. You can read more about the full range of licensed weight loss injections and how they compare before deciding what to explore further.
Health in Northern Ireland is a devolved matter, which means commissioning decisions about weight loss medicines are made separately from NHS England. The phased rollout that NICE outlined for tirzepatide (TA1026) applies directly to England; Northern Ireland, Scotland and Wales each set their own access frameworks.
In practice, NHS access to these medicines in Northern Ireland has been limited and largely confined to specialist weight management services. Waiting lists for those services are long in most trust areas, and many people who meet the clinical criteria still face waits of a year or more. If you're curious about how the picture looks in Scotland for comparison, our page on weight loss injections in Scotland covers the devolved access framework there.
The NHS England guidance on weight management injections is a useful reference for understanding the England picture, but residents of Northern Ireland should check with their GP or local health and social care trust for the most current local commissioning position. The situation is moving, and what's available in one trust area may differ from another.
For people who don't meet the current NHS threshold or don't want to wait, private treatment through a regulated pharmacy is the realistic alternative.
The licensed eligibility for these medicines is set by the medicines' marketing authorisations, not by NHS commissioning thresholds. For private treatment, a prescriber assesses against those criteria. Broadly, adults with a BMI of 30 or above qualify, as do adults with a BMI of 27 or above if they have at least one weight-related condition, examples include high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance.
A BMI figure alone doesn't decide the outcome. The prescriber looks at your full health picture: current medicines, medical history, any contraindications. Tirzepatide and semaglutide are not recommended during pregnancy, while breastfeeding, or when actively trying to conceive. They aren't licensed for under-18s. You can check the detailed eligibility criteria for weight loss injections if you want a fuller picture before starting a consultation.
If you're weighing up whether the treatment is right for you at all (not just whether you qualify) our page on whether weight loss injections are worth it covers the evidence and the practical considerations in more depth. It's worth a read before committing.
A regulated online pharmacy works the same way for someone in Belfast or Derry as it does for someone in Bristol, and if you want to see what's available locally before committing to a full consultation, our page on weight loss injections in Northampton is a useful example of how private treatment is structured across different UK locations. You complete a free consultation online, a GPhC-registered prescriber reads through your answers (not software, a real clinician) and if you're clinically suitable, a prescription is issued and your treatment is dispatched. At nume, orders placed by midday on a weekday are sent the same day once approved, arriving the next working day via DPD in plain, unbranded packaging. Delivery is free.
One quick check worth doing before handing over any payment to an online pharmacy: look it up on the GPhC pharmacy register. It takes about 30 seconds and confirms the pharmacy is legally registered to dispense prescription medicines in the UK. If a seller isn't on there, that's a firm reason to stop. The MHRA has repeatedly warned about counterfeit weight loss pens sold online, some containing dangerous substances. Checking the register costs nothing and takes less time than a cup of tea.
On price: private weight loss injections are not inexpensive. The cost varies by medicine and dose, and the total should include the consultation, prescription and delivery, not just the pen itself. You can find current pricing on our treatment options page, where everything is set out in one place with no hidden fees. If you'd like to read what others have found, there are independent accounts on our weight loss injection reviews page too.
When you feel ready, speaking to a prescriber is the natural next step. There's no obligation at the consultation stage, and it's the only way to find out whether treatment is right for your specific situation. Speak to our prescribers at any point, the consultation is free and reviewed the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.